Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-20-064504

Chief Operations Officer sold 7,000 shares at an average $23.11 ($161,735)

  • Chief Operations Officer acquired 3,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Newell Joe Chief Operations Officer 2020-12-16 Option exercise +3,500 $12.15 $42,525 120,055 D
Newell Joe Chief Operations Officer 2020-12-16 Sale −3,500 $23.13 $80,955 116,555 D
Newell Joe Chief Operations Officer 2020-12-16 Sale −3,500 $23.08 $80,780 113,055 D
Derivatives
Newell Joe Chief Operations Officer 2020-12-16 Option exercise · Employee Stock Option (Right to Buy) −3,146 49,187 D
Newell Joe Chief Operations Officer 2020-12-16 Option exercise · Employee Stock Option (Right to Buy) −354 13,813 D
Open-market sales · 7,000 sh · avg $23.11 · $161,735
Loading xslF345X03/doc4.xml…